• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

赫氏细胞甲状腺肿瘤中抗氧化基因的功能多态性——GPX1多态性与复发性赫氏细胞甲状腺癌的关联

Functional polymorphisms in antioxidant genes in Hurthle cell thyroid neoplasm - an association of GPX1 polymorphism and recurrent Hurthle cell thyroid carcinoma.

作者信息

Krhin Blaz, Goricar Katja, Gazic Barbara, Dolzan Vita, Besic Nikola

机构信息

Institute of Oncology Ljubljana, Slovenia.

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Slovenia.

出版信息

Radiol Oncol. 2016 Jul 19;50(3):289-96. doi: 10.1515/raon-2016-0031. eCollection 2016 Sep 1.

DOI:10.1515/raon-2016-0031
PMID:27679545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5024660/
Abstract

BACKGROUND

Hurthle cells of the thyroid gland are very rich in mitochondria and oxidative enzymes. As a high level oxidative metabolism may lead to higher level of oxidative stress and can be associated with an increased risk for cancer, we investigated whether common functional polymorphisms in antioxidant genes (SOD2, CAT, GPX, GSTP1, GSTM1 and GSTT1) are associated with the development or clinical course of Hurthle cell thyroid carcinoma (HCTC).

METHODS

A retrospective study was performed in 139 patients treated by thyroid surgery for a Hurthle cell neoplasm. HCTC, Hurthle cell thyroid adenoma (HCTA) or Hurthle cell thyroid nodule (HCTN) were diagnosed by pathomorphology. DNA was extracted from cores of histologically confirmed normal tissue obtained from formalin-fixed paraffin-embedded specimens and genotyped for investigated polymorphisms. Logistic regression was used to compare genotype distributions between patient groups.

RESULTS

HCTC, HCTA and HCTN were diagnosed in 53, 47 and 21 patients, respectively. Metastatic disease and recurrence of HCTC were diagnosed in 20 and 16 HCTC patients, respectively. Genotypes and allele frequencies of investigated polymorphisms did not deviate from Hardy-Weinberg equilibrium in patients with HCTC, HCTA and HCTN. Under the dominant genetic model we observed no differences in the genotype frequency distribution of the investigated polymorphisms when the HCTA and HCTN group was compared to the HCTC group for diagnosis of HCTC or for the presence of metastatic disease. However, GPX1 polymorphism was associated with the occurrence of recurrent disease (p = 0.040).

CONCLUSIONS

GPX1 polymorphism may influence the risk for recurrent disease in HCTC.

摘要

背景

甲状腺嗜酸性细胞富含线粒体和氧化酶。由于高水平的氧化代谢可能导致更高水平的氧化应激,并可能与癌症风险增加相关,我们研究了抗氧化基因(SOD2、CAT、GPX、GSTP1、GSTM1和GSTT1)中的常见功能多态性是否与嗜酸性细胞甲状腺癌(HCTC)的发生或临床病程相关。

方法

对139例接受甲状腺手术治疗嗜酸性细胞瘤的患者进行回顾性研究。通过病理形态学诊断HCTC、嗜酸性细胞甲状腺腺瘤(HCTA)或嗜酸性细胞甲状腺结节(HCTN)。从福尔马林固定石蜡包埋标本中获得的经组织学证实的正常组织核心中提取DNA,并对研究的多态性进行基因分型。使用逻辑回归比较患者组之间的基因型分布。

结果

分别在53、47和21例患者中诊断出HCTC、HCTA和HCTN。分别在20例和16例HCTC患者中诊断出转移性疾病和HCTC复发。在HCTC、HCTA和HCTN患者中,研究的多态性的基因型和等位基因频率未偏离哈迪-温伯格平衡。在显性遗传模型下,当将HCTA和HCTN组与HCTC组进行比较以诊断HCTC或存在转移性疾病时,我们观察到研究的多态性的基因型频率分布没有差异。然而,GPX1多态性与复发性疾病的发生相关(p = 0.040)。

结论

GPX1多态性可能影响HCTC复发性疾病的风险。

相似文献

1
Functional polymorphisms in antioxidant genes in Hurthle cell thyroid neoplasm - an association of GPX1 polymorphism and recurrent Hurthle cell thyroid carcinoma.赫氏细胞甲状腺肿瘤中抗氧化基因的功能多态性——GPX1多态性与复发性赫氏细胞甲状腺癌的关联
Radiol Oncol. 2016 Jul 19;50(3):289-96. doi: 10.1515/raon-2016-0031. eCollection 2016 Sep 1.
2
The role of radioactive iodine in the treatment of Hürthle cell carcinoma of the thyroid.放射性碘在甲状腺许特莱细胞癌治疗中的作用。
Thyroid. 2003 Jun;13(6):577-84. doi: 10.1089/105072503322238845.
3
Neoadjuvant chemotherapy in 29 patients with locally advanced follicular or Hürthle cell thyroid carcinoma: a phase 2 study.29 例局部晚期滤泡或 Hurthle 细胞甲状腺癌患者的新辅助化疗:一项 2 期研究。
Thyroid. 2012 Feb;22(2):131-7. doi: 10.1089/thy.2011.0243. Epub 2011 Dec 16.
4
Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience.32例甲状腺嗜酸性细胞癌远处转移患者的治疗及预后:单机构经验
BMC Cancer. 2016 Feb 26;16:162. doi: 10.1186/s12885-016-2179-3.
5
Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma.胡尔希细胞癌患者中miRNA的表达与远处转移的发生
Int J Endocrinol. 2016;2016:8945247. doi: 10.1155/2016/8945247. Epub 2016 Jul 28.
6
Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma.肽受体放射性核素治疗非放射性碘亲和性分化型甲状腺癌
J Nucl Med. 2005 Jan;46 Suppl 1:107S-14S.
7
Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence.抗氧化防御相关基因变异与儿童或青少年恶性肿瘤治疗后继发性甲状腺癌的较高风险无关。
Radiol Oncol. 2016 Feb 16;50(1):80-6. doi: 10.1515/raon-2015-0026. eCollection 2016 Mar 1.
8
Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?在甲状腺细针穿刺中,嗜酸性细胞病变/肿瘤比滤泡性病变/肿瘤更能预测恶性肿瘤吗?
Diagn Cytopathol. 2006 May;34(5):330-4. doi: 10.1002/dc.20440.
9
Isolated Liver Metastasis in Hürthle Cell Thyroid Cancer Treated with Microwave Ablation.微波消融治疗甲状腺嗜酸性细胞癌的孤立性肝转移
Case Rep Endocrinol. 2017;2017:2790741. doi: 10.1155/2017/2790741. Epub 2017 Jan 9.
10
Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease.以嗜酸性细胞为主的细针穿刺活检标本:结节性甲状腺疾病管理中的一个难题。
Surgery. 2005 Oct;138(4):650-6; discussion 656-7. doi: 10.1016/j.surg.2005.06.047.

引用本文的文献

1
Genetic variability in the glucocorticoid pathway and treatment outcomes in hospitalized patients with COVID-19: a pilot study.新冠病毒肺炎住院患者糖皮质激素途径的基因变异性与治疗结果:一项初步研究
Front Pharmacol. 2024 Jul 29;15:1418567. doi: 10.3389/fphar.2024.1418567. eCollection 2024.
2
Synchronous occurrence of Hurthle cell carcinoma with Hodgkin's lymphoma; the first reported case with literature review.嗜酸性细胞癌与霍奇金淋巴瘤同时发生;首例报道病例并文献复习
Ann Med Surg (Lond). 2021 Aug 24;69:102750. doi: 10.1016/j.amsu.2021.102750. eCollection 2021 Sep.
3
The Molecular Landscape of Hürthle Cell Thyroid Cancer Is Associated with Altered Mitochondrial Function-A Comprehensive Review.Hürthle 细胞甲状腺癌的分子特征与线粒体功能改变有关——一篇全面的综述。
Cells. 2020 Jun 27;9(7):1570. doi: 10.3390/cells9071570.
4
Approach the Invasive Potential with Hurthle Cell Tumors of Thyroid.探讨甲状腺嗜酸性细胞肿瘤的侵袭潜能。
Pathol Oncol Res. 2019 Apr;25(2):697-701. doi: 10.1007/s12253-018-0546-x. Epub 2018 Dec 11.
5
Glutathione peroxidases as oncotargets.谷胱甘肽过氧化物酶作为肿瘤靶点。
Oncotarget. 2017 Aug 16;8(45):80093-80102. doi: 10.18632/oncotarget.20278. eCollection 2017 Oct 3.

本文引用的文献

1
Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence.抗氧化防御相关基因变异与儿童或青少年恶性肿瘤治疗后继发性甲状腺癌的较高风险无关。
Radiol Oncol. 2016 Feb 16;50(1):80-6. doi: 10.1515/raon-2015-0026. eCollection 2016 Mar 1.
2
Oxidative stress and its significant roles in neurodegenerative diseases and cancer.氧化应激及其在神经退行性疾病和癌症中的重要作用。
Int J Mol Sci. 2014 Dec 24;16(1):193-217. doi: 10.3390/ijms16010193.
3
Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma.8-羟基脱氧鸟苷(8-OHdG)与氧化应激在甲状腺乳头状癌中的作用研究
Tumour Biol. 2015 Apr;36(4):2667-74. doi: 10.1007/s13277-014-2889-6. Epub 2014 Dec 2.
4
Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experience.108例许特莱细胞甲状腺癌患者疾病特异性生存的预后因素:单机构经验
BMC Cancer. 2014 Oct 23;14:777. doi: 10.1186/1471-2407-14-777.
5
Clinical and molecular features of Hürthle cell carcinoma of the thyroid.甲状腺嗜酸性细胞癌的临床及分子特征
J Clin Endocrinol Metab. 2015 Jan;100(1):55-62. doi: 10.1210/jc.2014-1634.
6
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.通过 ThyroSeq v2 下一代测序检测,对甲状腺结节滤泡性肿瘤/滤泡性肿瘤细胞学不典型的患者进行高度准确的癌症诊断。
Cancer. 2014 Dec 1;120(23):3627-34. doi: 10.1002/cncr.29038. Epub 2014 Sep 10.
7
Oxidative stress in graves' disease.格雷夫斯病中的氧化应激。
Eur Thyroid J. 2012 Jul;1(2):80-7. doi: 10.1159/000337976. Epub 2012 Jun 7.
8
Polymorphisms of methylenetetrahydrofolate reductase and glutathione S-transferase are not associated with the risk of papillary thyroid cancer in Korean population.亚甲基四氢叶酸还原酶和谷胱甘肽S-转移酶的多态性与韩国人群甲状腺乳头状癌的风险无关。
Mol Biol Rep. 2014 Jun;41(6):3793-9. doi: 10.1007/s11033-014-3245-z. Epub 2014 Feb 18.
9
The role of thyroid hormones as inductors of oxidative stress and neurodegeneration.甲状腺激素作为氧化应激和神经退行性变诱导物的作用。
Oxid Med Cell Longev. 2013;2013:218145. doi: 10.1155/2013/218145. Epub 2013 Dec 9.
10
Association between polymorphisms in glutathione peroxidase and selenoprotein P genes, glutathione peroxidase activity, HRT use and breast cancer risk.谷胱甘肽过氧化物酶和硒蛋白 P 基因多态性、谷胱甘肽过氧化物酶活性、HRT 使用与乳腺癌风险的关联。
PLoS One. 2013 Sep 10;8(9):e73316. doi: 10.1371/journal.pone.0073316. eCollection 2013.